[go: up one dir, main page]

GB0000113D0 - The use of triazolo-pyridazine derivatives for treating premenstrual syndrome - Google Patents

The use of triazolo-pyridazine derivatives for treating premenstrual syndrome

Info

Publication number
GB0000113D0
GB0000113D0 GBGB0000113.1A GB0000113A GB0000113D0 GB 0000113 D0 GB0000113 D0 GB 0000113D0 GB 0000113 A GB0000113 A GB 0000113A GB 0000113 D0 GB0000113 D0 GB 0000113D0
Authority
GB
United Kingdom
Prior art keywords
triazolo
premenstrual syndrome
pyridazine derivatives
treating premenstrual
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0000113.1A
Other versions
GB2345443A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon Pharma UK Ltd
Original Assignee
Merck Sharp and Dohme Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp and Dohme Ltd filed Critical Merck Sharp and Dohme Ltd
Publication of GB0000113D0 publication Critical patent/GB0000113D0/en
Publication of GB2345443A publication Critical patent/GB2345443A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB0000113A 1999-01-08 2000-01-05 Use of triazolo-pyridazines for treating premenstrual syndrome Withdrawn GB2345443A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9900453 1999-01-08

Publications (2)

Publication Number Publication Date
GB0000113D0 true GB0000113D0 (en) 2000-02-23
GB2345443A GB2345443A (en) 2000-07-12

Family

ID=10845800

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0000113A Withdrawn GB2345443A (en) 1999-01-08 2000-01-05 Use of triazolo-pyridazines for treating premenstrual syndrome

Country Status (1)

Country Link
GB (1) GB2345443A (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9801397D0 (en) * 1998-01-22 1998-03-18 Merck Sharp & Dohme Therapeutic agents
US7572807B2 (en) 2005-06-09 2009-08-11 Bristol-Myers Squibb Company Heteroaryl 11-beta-hydroxysteroid dehydrogenase type I inhibitors
PH12012501361A1 (en) 2009-12-31 2012-10-22 Centro Nac De Investigaciones Oncologicas Cnio Tricyclic compounds for use as kinase inhibitors
WO2012098387A1 (en) 2011-01-18 2012-07-26 Centro Nacional De Investigaciones Oncológicas (Cnio) 6, 7-ring-fused triazolo [4, 3 - b] pyridazine derivatives as pim inhibitors
WO2013004984A1 (en) 2011-07-07 2013-01-10 Centro Nacional De Investigaciones Oncologicas (Cnio) Tricyclic compounds for use as kinase inhibitors
WO2013005057A1 (en) 2011-07-07 2013-01-10 Centro Nacional De Investigaciones Oncológicas (Cnio) New compounds
WO2013005041A1 (en) 2011-07-07 2013-01-10 Centro Nacional De Investigaciones Oncológicas (Cnio) Tricyclic heterocyclic compounds as kinase inhibitors
CN112979655A (en) * 2019-12-16 2021-06-18 上海赛默罗生物科技有限公司 Triazolopyridazine derivative, preparation method, pharmaceutical composition and application thereof
CN114591352B (en) * 2022-05-11 2022-09-09 上海赛默罗生物科技有限公司 A kind of triazolopyridazine compound and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4216905B2 (en) * 1996-07-25 2009-01-28 メルク シヤープ エンド ドーム リミテツド Substituted triazolopyridazine derivatives as ligands for GABA receptors
WO1999025353A1 (en) * 1997-11-13 1999-05-27 Merck Sharp & Dohme Limited Therapeutic uses of triazolo-pyridazine derivatives
EP1047697A1 (en) * 1998-01-14 2000-11-02 MERCK SHARP & DOHME LTD. Triazolo-pyridazine derivatives as ligands for gaba receptors
GB9813576D0 (en) * 1998-06-24 1998-08-19 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
GB2345443A (en) 2000-07-12

Similar Documents

Publication Publication Date Title
ZA200107291B (en) Use of xenon for treating neurointoxications.
HUP0202807A3 (en) Compounds for the treatment of ischemia
IL196301A0 (en) Medicament for the treatment of hapatitis c
IL144043A0 (en) Reovirus for the treatment of cellular proliferative disorders
PT1147083E (en) ARILPIPERAZINYL-CYCLOHEXYLINDOLE DERIVATIVES FOR THE TREATMENT OF DEPRESSION
IL151890A0 (en) Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
HUP0200864A3 (en) Use of macrolide compounds for the treatment of dry eye
IL148579A0 (en) Oncolytic combinations for the treatment of cancer
GB2354708B (en) Compositions for the treatment of wound contracture
AU2001260834A1 (en) The treatment of herpes
GB0000113D0 (en) The use of triazolo-pyridazine derivatives for treating premenstrual syndrome
GB9816234D0 (en) Compounds for use in the treatment of inflammation
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
IL151891A0 (en) Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
SI1197485T1 (en) Cyclobuten-dione derivatives for use in the treatment of artherosclerosis
IL148640A0 (en) Processes for the preparation of sumatriptan and related compounds
IL133760A0 (en) Composition for the treatment of dandruff
HUP0203407A3 (en) Process for the preparation of pyrazolopyridazine derivatives
IL144115A0 (en) Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections
GB2363605B (en) Process for the preparation of alpha-aminoketone derivatives
HUP0202865A3 (en) Process for the preparation of 2-cyanopyridines
AU3759800A (en) Treatment of premenstrual syndrome
IL138691A (en) Process for the preparation of 3-acyl-indoles
GB9922462D0 (en) The use of triazolo-pyridazine derivatives for treating hearing loss
SI1068184T1 (en) N-aryloxyethylamine derivatives for the treatment of depression

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)